In conclusion, our results indicate that dual BTK and MDM2 inhibition was able to induce a robust apoptosis of B-CLL cells in a microenvironment protection setting with mitochondria involvement. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.